Silence Therapeutics plc Capital Expenditures
Silence Therapeutics plc (SLNCF) reported Capital Expenditures of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-10
- Silence Therapeutics plc payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- Silence Therapeutics plc payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- Silence Therapeutics plc payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- Silence Therapeutics plc payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $3.00K, a 95.31% decline year-over-year.
- Silence Therapeutics plc payments to acquire property, plant, and equipment for fiscal 2025 was $55.00K, a 73.93% decline from fiscal 2024.
- Silence Therapeutics plc payments to acquire property, plant, and equipment for fiscal 2024 was $211.00K, a 276.79% increase from fiscal 2023.
- Silence Therapeutics plc payments to acquire property, plant, and equipment for fiscal 2023 was $56.00K, a 67.63% decline from fiscal 2022.
- Silence Therapeutics plc payments to acquire property, plant, and equipment for fiscal 2022 was $173.00K.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $0.00 10-Q · filed 2026-08-10 | $0.00 derived: sum of 3 quarters · filed 2026-08-10 | $3.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-07 | $0.00 derived: sum of 2 quarters · filed 2026-05-07 | $3.00K derived: sum of 3 quarters · filed 2026-05-07 | $51.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $3.00K derived: sum of 2 quarters · filed 2026-03-05 | $51.00K derived: sum of 3 quarters · filed 2026-08-10 | $55.00K 10-K · filed 2026-03-05 |
| 2025-09-30 | $3.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $51.00K derived: sum of 2 quarters · filed 2026-08-10 | $55.00K 10-Q · filed 2025-11-06 | $117.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | $48.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $52.00K 10-Q · filed 2026-08-10 | $114.00K derived: sum of 3 quarters · filed 2026-08-10 | $178.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | $4.00K 10-Q · filed 2026-05-07 | $66.00K derived: sum of 2 quarters · filed 2026-05-07 | $130.00K derived: sum of 3 quarters · filed 2026-05-07 | $215.00K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $62.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $126.00K derived: sum of 2 quarters · filed 2026-03-05 | $211.00K derived: sum of 3 quarters · filed 2026-03-05 | $211.00K 10-K · filed 2026-03-05 |
| 2024-09-30 | $64.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $149.00K derived: sum of 2 quarters · filed 2025-11-06 | $149.00K 10-Q · filed 2025-11-06 | |
| 2024-06-30 | $85.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $85.00K 10-Q · filed 2025-08-07 | ||
| 2024-03-31 | $0.00 10-Q · filed 2025-05-08 | |||
| 2023-12-31 | $56.00K 10-K · filed 2025-02-27 | |||
| 2022-12-31 | $173.00K 10-K · filed 2025-02-27 |